1. miRNA signatures in childhood sarcomas and their clinical implications
   G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
2. MicroRNA‑574‑3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28
   Zhongming Zha et al, 2020, Oncology Letters CrossRef
3. miR‑188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma
   Lu Pan et al, 2018, Molecular Medicine Reports CrossRef
4. MicroRNA-302a/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7/AKT axis
   Yu-Shui Ma et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
5. Long non-coding RNA ASMTL-AS1 deteriorates the oncogenicity of osteosarcoma by decoying microRNA-342–3p and consequently raising ADAM9 expression
   Chengcai Hou et al, 2021, Biochemical and Biophysical Research Communications CrossRef
6. microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9
   Weili Chen et al, 2020, Bioscience Reports CrossRef
7. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells
   Xiaobo Feng et al, 2020, Oncology Research and Treatment CrossRef
8. Research Progress of ADAM9 in the Biology of Solid Tumors
   莉金 朱, 2020, Advances in Clinical Medicine CrossRef
9. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis
   Xin Pan et al, 2018, Cell Death & Disease CrossRef